| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-328X(96)00277-X |
| P698 | PubMed publication ID | 9191083 |
| P2093 | author name string | Ramos JA | |
| Romero J | |||
| Fernandez-Ruiz JJ | |||
| Castro JG | |||
| Garcia-Gil L | |||
| Garcia-Palomero E | |||
| P2860 | cites work | Neurobiology of marijuana abuse. | Q36208840 |
| The cannabinoid receptor: biochemical, anatomical and behavioral characterization | Q36605535 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Molecular mechanisms of membrane receptor desensitization. | Q40491298 | ||
| Search for endogenous ligands of the cannabinoid receptor | Q40643774 | ||
| Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study | Q42617028 | ||
| Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles | Q44970457 | ||
| Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain | Q45091218 | ||
| Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment | Q48209713 | ||
| Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors | Q48741838 | ||
| Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments | Q67651161 | ||
| Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study | Q69337584 | ||
| Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol | Q72061444 | ||
| Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study | Q72110282 | ||
| Molecular cloning of a human cannabinoid receptor which is also expressed in testis | Q24337626 | ||
| Cannabinoid receptor localization in brain | Q24558751 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor | Q34358410 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 100-108 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Molecular Brain Research | Q6895939 |
| P1476 | title | Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions | |
| P478 | volume | 46 |
| Q44898084 | A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. |
| Q40647052 | Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects. |
| Q35740630 | Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels |
| Q35626928 | Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. |
| Q37237991 | Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis |
| Q47926400 | CB1 and CB2 Receptor Pharmacology |
| Q30497212 | Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. |
| Q42906961 | Cannabinoid effects on CB1 receptor density in the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210 |
| Q42469712 | Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol |
| Q48165974 | Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide |
| Q27336451 | Cannabinoids and Epilepsy. |
| Q98288614 | Cannabinoids, Endocannabinoids and Sleep |
| Q30807024 | Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data |
| Q48405803 | Cannabis and endogenous cannabinoid systems. |
| Q48428637 | Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. |
| Q35982298 | Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways |
| Q73665693 | Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions |
| Q28590486 | Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system |
| Q43408201 | Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats |
| Q36752224 | Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density |
| Q30430922 | Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies |
| Q35546602 | Differential effects of psychoactive drugs in adolescents and adults |
| Q34191520 | Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1. |
| Q48127886 | Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro |
| Q42538098 | Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs |
| Q42538308 | Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions |
| Q30687668 | Endocannabinoid signaling in the etiology and treatment of major depressive illness |
| Q44288438 | Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study |
| Q46147054 | HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat. |
| Q87795568 | Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse |
| Q47645123 | Longitudinal associations of social cognition and substance use in childhood and early adolescence: findings from the Avon Longitudinal Study of Parents and Children. |
| Q36712200 | Marijuana dependence: not just smoke and mirrors |
| Q34363232 | Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure |
| Q34990029 | Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome |
| Q35688747 | Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation |
| Q37038999 | Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain |
| Q34302209 | Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms |
| Q34185013 | Pharmacokinetics and pharmacodynamics of cannabinoids |
| Q28078759 | Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? |
| Q87255327 | Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis |
| Q46460361 | Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects. |
| Q36945634 | Reduced Brain Cannabinoid Receptor Availability in Schizophrenia |
| Q38019926 | Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors |
| Q34167852 | Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat |
| Q34524803 | Striatal dopamine neurotransmission: regulation of release and uptake |
| Q34786835 | Study of cannabinoid dependence in animals |
| Q26798096 | The Brain on Drugs: From Reward to Addiction |
| Q33824661 | The effects of cannabinoids on serum cortisol and prolactin in humans |
| Q28137626 | The effects of cannabinoids on the brain |
| Q33720155 | The effects of cannabinoids on the regulation of reproduction |
| Q44275827 | The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q36196473 | The use of cannabinoids in multiple sclerosis |
| Q44874932 | Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice |
| Q48374331 | Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol |
| Q28372719 | Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen |
| Q33347190 | Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol. |
| Q42722527 | Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence |
| Q39283967 | [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users |
| Q98177380 | hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation |
Search more.